Victory Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.8K Sell
23,202
-420
-2% -$413 ﹤0.01% 2436
2025
Q1
$34K Sell
23,622
-149,461
-86% -$215K ﹤0.01% 2393
2024
Q4
$381K Buy
173,083
+148,456
+603% +$327K ﹤0.01% 2097
2024
Q3
$40.6K Buy
24,627
+2,417
+11% +$3.99K ﹤0.01% 2403
2024
Q2
$49.3K Sell
22,210
-1,969
-8% -$4.37K ﹤0.01% 2370
2024
Q1
$64.8K Buy
24,179
+8,981
+59% +$24.1K ﹤0.01% 2354
2023
Q4
$45.4K Buy
15,198
+3,558
+31% +$10.6K ﹤0.01% 2448
2023
Q3
$11.4K Buy
11,640
+1,372
+13% +$1.35K ﹤0.01% 2478
2023
Q2
$14.3K Buy
+10,268
New +$14.3K ﹤0.01% 2470
2021
Q3
Sell
-17,390
Closed -$368K 2794
2021
Q2
$368K Sell
17,390
-689
-4% -$14.6K ﹤0.01% 2346
2021
Q1
$507K Sell
18,079
-816
-4% -$22.9K ﹤0.01% 2199
2020
Q4
$491K Sell
18,895
-929
-5% -$24.1K ﹤0.01% 2088
2020
Q3
$737K Sell
19,824
-7,290
-27% -$271K ﹤0.01% 1831
2020
Q2
$1.39M Buy
27,114
+138
+0.5% +$7.08K ﹤0.01% 1570
2020
Q1
$850K Buy
26,976
+12,067
+81% +$380K ﹤0.01% 1906
2019
Q4
$889K Buy
14,909
+707
+5% +$42.2K ﹤0.01% 1786
2019
Q3
$521K Buy
14,202
+13,929
+5,102% +$511K ﹤0.01% 1868
2019
Q2
$13K Hold
273
﹤0.01% 1802
2019
Q1
$11K Hold
273
﹤0.01% 1762
2018
Q4
$13K Sell
273
-52
-16% -$2.48K ﹤0.01% 1754
2018
Q3
$14K Buy
325
+43
+15% +$1.85K ﹤0.01% 1777
2018
Q2
$11K Hold
282
﹤0.01% 1809
2018
Q1
$20K Hold
282
﹤0.01% 1790
2017
Q4
$19K Hold
282
﹤0.01% 1789
2017
Q3
$14K Hold
282
﹤0.01% 1794
2017
Q2
$13K Buy
282
+5
+2% +$230 ﹤0.01% 1790
2017
Q1
$10K Hold
277
﹤0.01% 1789
2016
Q4
$3K Buy
277
+17
+7% +$184 ﹤0.01% 1787
2016
Q3
$4K Buy
260
+18
+7% +$277 ﹤0.01% 1772
2016
Q2
$2K Buy
242
+5
+2% +$41 ﹤0.01% 1630
2016
Q1
$4K Buy
237
+18
+8% +$304 ﹤0.01% 1656
2015
Q4
$5K Buy
219
+12
+6% +$274 ﹤0.01% 1672
2015
Q3
$5K Buy
207
+20
+11% +$483 ﹤0.01% 1613
2015
Q2
$15K Buy
+187
New +$15K ﹤0.01% 1608